How should patients buy ruxolitinib cream (Opzelura) to treat vitiligo and what precautions should be taken

Ruxolitinib cream (Opzelura, composed of Ruxolitinib) is a topical JAK inhibitor, mainly used to treat non-segmental vitiligo (white spots) and some inflammatory skin diseases. Clinical studies have shown that the drug can improve skin pigmentation in patients with vitiligo by regulating immune responses and promoting the recovery of melanocytes. Due to its remarkable efficacy, Opzelura has attracted widespread attention after being approved for marketing in Europe and the United States, and is regarded as a new breakthrough in the treatment of vitiligo in recent years.

Currently, ruxolitinib cream is not yet available in China, so patients cannot purchase it through regular domestic pharmacies or hospitals. If you need to use this drug, it can only be obtained through overseas channels. The price of foreign original medicines is relatively high, with one dose often costing more than 10,000 yuan. There are also some relatively cheap generic versions abroad, such as Bangladesh generic drugs, which cost about a few hundred yuan, and their main ingredients are basically the same as the original drugs, making them an economical choice for some patients.

If domestic patients want to use ruxolitinib cream, they usually need to obtain it through overseas purchasing agents, cross-border medical service platforms or international pharmacies . When choosing channels, you should try to choose formal institutions with qualifications and high credibility, and avoid using personal purchasing agents or channels from unknown sources to prevent the purchase of fake medicines or inferior products. In addition, it is recommended to keep the doctor's prescription or medical records before purchasing so that you can obtain professional guidance during the medication process.

Although ruxolitinib cream has shown good efficacy in clinical practice abroad, patients still need to consult a professional dermatologist before use to clarify the scope of application and medication specifications. Common side effects include mild erythema, skin irritation, or itching, which are mostly tolerable. Long-term use requires vigilance against potential risks such as abnormal local immune response. Therefore, it is recommended that patients use it rationally under the guidance of a doctor and avoid increasing or decreasing the frequency or dosage of medication on their own. Overall, ruxolitinib cream brings new hope to patients with vitiligo, but purchase and use must be done with caution to ensure safety and efficacy.

Reference materials:https://www.drugs.com/